Pharmaceuticals

Reproductive Health Market Trends Weight Loss Treatments Biotechnology Dietary Impact AI Infrastructure Patient Advocacy Executive Orders Patient Rights Experimental Techniques

RFK Jr. Weighs New Limits on TV Drug Advertising

They aim to curb misleading drug marketing by demanding fuller risk disclosures or revoking industry tax deductions.

Stories older than 24h

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

AI-Powered Discovery Yields WYS-694, a Broad-Spectrum Coronavirus Antiviral

Sanders and King Introduce Bill to Ban Direct-to-Consumer Prescription Drug Ads

Ozempic and Wegovy Users Face Dental Decay and Unusual Scent Cravings

FDA Commissioner Pledges Safety Review of Abortion Pill Mifepristone

Nvidia Partners with Swedish Consortium to Build Country’s Biggest Enterprise AI Supercomputer

Ozempic injections fuel £24 billion gourmand perfume boom

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Trump Administration Begins Enforcing Prescription Drug Price Controls

U.S. Drug Launch Prices Skyrocket, Driven by Rare Disease Treatments

Noom Introduces Personalized Microdoses of Compounded Wegovy Ahead of FDA Deadline

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

HHS Orders FDA Review of Mifepristone Amid Debate Over Flawed Safety Study

Researchers Identify Broad-Spectrum Inhibitors for Malaria Parasite's Key Protein Family

Regulators Intensify Warnings on Unregulated Nasal Tanning Sprays Over Health Risks

Study Unveils Acetaminophen’s Pain Relief Mechanism After Decades of Mystery

WW International Files for Bankruptcy, Signaling End of Iconic WeightWatchers Era

Novo Nordisk CEO Steps Down Following Share Price Collapse